Using next-generation sequencing to understand the phylogenetics and networks of generalised HIV epidemics in Africa

European Meeting on HIV & Hepatitis 2020

Number, type and cost of microbiological assays during HIV Pre-Exposure Prophylaxis: the experience of a French hospital

European Meeting on HIV & Hepatitis 2020

Breaking bad: Chems, sex and sexual health

European Meeting on HIV & Hepatitis 2020

Using next-generation sequencing to assess the differences in HIV drug resistance pre- and post-treatment in a Treatment as Prevention Trial

European Meeting on HIV & Hepatitis 2020

Knowledge, attitude and practice survey about blood borne infections among Georgian health care workers

European Meeting on HIV & Hepatitis 2020

Determination of drug resistance of hepatitis C virus to NS5A protein inhibitors as a new approach to personalized medicine

European Meeting on HIV & Hepatitis 2020

Next generation sequencing for routine HIV-1 resistance genotyping in a clinical laboratory: unsolved issues

European Meeting on HIV & Hepatitis 2020

Association of viral reservoir with HIV infection duration, viral load and CD4 count

European Meeting on HIV & Hepatitis 2020

Comparison of the Vela Dx Sentosa and in-house MiSeq Next-Generation Sequencing Systems for HIV-1 DNA Genotypic Resistance

European Meeting on HIV & Hepatitis 2020

Creation of an Italian HIV DNA Network for the validation and clinical use of HIV-1 DNA quantification assays

European Meeting on HIV & Hepatitis 2020

Exploratory evaluation for the optimization of next generation sequencing HIV-1 drug resistance outcomes based on an in-house RNA extraction protocol

European Meeting on HIV & Hepatitis 2020

Associations between vitamin D and fibrosis, genotype, viral load in patients having chronic hepatitis C

European Meeting on HIV & Hepatitis 2020

Overview of the national hepatitis B viral load testing programe in Uganda

European Meeting on HIV & Hepatitis 2020

Comparison of the new Alinity m system with the established Abbott RealTime and Hologic Aptima Quant Assay in HIV-1, HCV and HBV viral load measurement including performance and turn-around times

European Meeting on HIV & Hepatitis 2020

The Significance of M2BPGi Marker and CCC DNA in Unknown Etiology Hepatitis

European Meeting on HIV & Hepatitis 2020

A pan-genotypic nearly whole genome amplification approach of HCV by a simple two-step RT-PCR combined with parallel Oxford Nanopore and Illumina sequencing produce highly accurate long-range sequences

European Meeting on HIV & Hepatitis 2020

A hybrid sequencing approach for accurate minority detection and resolving haplotype information

European Meeting on HIV & Hepatitis 2020

The quantification of HBeAg levels differ among the different phases of HBV infection, and can predict therapeutic outcome in the setting of immunosuppression driven HBV reactivation.

European Meeting on HIV & Hepatitis 2020

The effectiveness of the application of serological tests and laboratory indicators as part of RITA for the detection of recent HIV infection

European Meeting on HIV & Hepatitis 2020

Combined use of high-sensitivity serological and virological HBV markers can make better in predicting the occurrence of HBV reactivation and to optimize prophylaxis duration in HBsAg-neg/anti-HBc-pos patients in the context of oncohematological diseases.

European Meeting on HIV & Hepatitis 2020

Ibalizumab shows in vitro activity against group A and group B HIV-2 clinical isolates

European Meeting on HIV & Hepatitis 2020

TDR surveillance and clinically relevant resistance in Spain: 2019 update

European Meeting on HIV & Hepatitis 2020

Prevalence of drug resistance mutations to rilpivirine and doravirine among NNRTI-experienced patients in Italy

European Meeting on HIV & Hepatitis 2020

HCV resistance associated variants following directly acting agent therapy failure- real life data from Poland

European Meeting on HIV & Hepatitis 2020